Morning Session

Regulation,Outlook and Trend

Compliance, Quality and Data Integrity

Strategic Partnerships & Clinical Outsourcing

Afternoon Session

Patient Centric, Site Selection and Project Management

Innovation ,Technology and Analytics

Oncology Drug Development ,Biologics & Biosimilar

Summit Background

Over the years, China has increasingly become the hotbed and destination for the clinical research. From one side, increasingly global pharmaceutical companies have recognized the importance and advantages to integrate China into the global early and late phase clinical development but also meanwhile the china clinical research markets are further driven and facilitated by the rapidly transforming China Local R&D Innovation.

A part of our highly successful Clinical Trials series, the event, which attracts over 150 attendees, will build upon CTLCS 2017 and examine partnerships and outsourcing strategies; key regulatory changes and the effects these have had on china market access; best practice techniques in clinical operations; Data Integrity, Quality & Risk Management; and also address the need to adopt Innovative Technology to ensure safety, transparency and quality as well as the hurdles of Oncology Drug Development ,Biologics & Biosimilar so as to keep up to date with the pace of growth in the region and maintain the clinical trials boom in Asia.

Previous and current speakers
  • Joseph Scheeren
    Senior VP,Head of Global Regulatory
    Bayer Healthcare, China
  • Stewart Geary
    Senior Vice President, Chief Medical Officer
    Corporate Medical Affairs Headquarters, Eisai, Japan
  • Yao-Chang Xu
    CEO
    Abbisko Therapeutics Co., Ltd., China
  • Joe Zhou
    CEO
    Walvax, China
  • Wu Tai Xiang
    Director
    Chinese Clinical Trials Registry, China
  • George Liu
    Vice President, Early Development
    Harbour Biomed, China
  • Patrick Kos
    VP Compliance
    Roche China
  • Nellie Chen
    Director of Clinical Operations
    ASLAN Pharmaceuticals, China
  • Dr Wang Ji Yao
    Huashan Hospital
    Huashan Hospital Shanghai Fudan University, China
  • Fred Li Yong-Guo
    Vice President, Pharmaceutical R&D
    Hua Medicine (Shanghai) Limited, China
  • James Cheong
    Senior Director of Clinical Operations
    Boehringer Ingelheim, China
  • George Guo
    GMO Country Head
    Novartis Pharmaceuticals (China) Oncology, China
  • Paul Kong
    Director of Clinical Operations
    Fibrogen, China
  • Xin Zhang
    Senior Director, Clinical Operations
    Shanghai Henlius Biotech Co Ltd, China
  • Rebecca Dai
    Head Clinical Project Management
    Bayer Pharmaceuticals, China
  • Wang Hao
    Head of Clinical Operations
    Bristol Myers Squibbs Pte Ltd, China
  • Helen Lin
    Executive Medical Director
    Amgen, China
  • Zhao Xianfeng
    Head of Clinical Research
    Abbott Nutrition R&D, China
  • Ye Hua
    SVP,Head of Clinical Development
    HUTCHISON MEDIPHARMA
  • Simon Li
    Vice President, Global Clinical Development
    LUYE PHARMA
  • Dennis Wong
    Associate VP, Head of Clinical Development, AP
    Sanofi
  • Ning Xu
    EVP,Head of Clinical Development
    ZAI LABORATORY
  • Joan Shen
    Vice President, Development Head China R&D
    JANSSEN PHARMACEUTICAL
  • Zaiqi Wang
    Head of Clinical Research, Executive Director
    MSD CHINA DEVELOPMENT CENTER
Who should attend?
More than 150 participants are expected to attend “Clincal Trials Leaders China Summit 2017”, attracting the strong contingent throughout the Asia Pacific, USA and Europe. To breakdown, the participants will mainly come from:
By Attendees:
  • Biometrics (Data Management and Biostatistics, Clinical Programming)
  • Clinical Research, Development, Sciences
  • Project Management, Clinical Operation
  • Medical Affairs, Writing, Protocol Development
  • Regulatory Submission, Affairs
  • Site Management and Monitoring
  • Regulatory Agencies and Authorities
  • Quality Assurance and Oversight Management
  • R&D, Clinical Procurement and Contracts development
  • Drug Safety and Pharmacoviligance
  • Principal Investigator
  • Clinical Supply Management
  • Others
By Industry:
  • Pharmas/Biopharmas
  • Biotechs
  • Research institutes/Hospitals
  • Academia
  • Clinical Research/Clinical Trials
  • Supply Chain Solution
  • Compliance and Validation
  • Services
  • Contract Research Services
  • Central Lab Services
  • Diagnostic Equipment/Services
  • Database/Data management service
  • Electronic Data Capaturing Systems
  • Clinical Trial Management System
  • Clinical research consulting service
  • Imaging Systems/ Imaging Analysis
  • Site management organization
  • Recruitment Agencies
  • Legal Companies
  • Bio Parks
Media outlets
  • GBI
  • MedSci
  • Lingmed
  • Pharmavoice
  • outsourcing pharma
  • biospectrumasia
  • Biopharma-asia
  • Pharma China
  • 丁香园
  • 生物探索
  • BIO-EQUIP
  • pharmaphorum’s

For more information,pls contact us by 021-31602153 or Email to marketing@wbfgroup.com